Mary Linton Peters, Judy E Garber, Nadine Tung. Gynecol Oncol 2017
Times Cited: 8
Times Cited: 8
Times Cited
Times Co-cited
Similarity
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
Neda Stjepanovic, Jan Lubinski, Pal Moller, Susan Randall Armel, William D Foulkes, Nadine Tung, Susan L Neuhausen, Joanne Kotsopoulos, Ping Sun, Sophie Sun,[...]. Breast Cancer Res Treat 2021
Neda Stjepanovic, Jan Lubinski, Pal Moller, Susan Randall Armel, William D Foulkes, Nadine Tung, Susan L Neuhausen, Joanne Kotsopoulos, Ping Sun, Sophie Sun,[...]. Breast Cancer Res Treat 2021
100
Routine TP53 testing for breast cancer under age 30: ready for prime time?
Jeanna M McCuaig, Susan R Armel, Ana Novokmet, Ophira M Ginsburg, Rochelle Demsky, Steven A Narod, David Malkin. Fam Cancer 2012
Jeanna M McCuaig, Susan R Armel, Ana Novokmet, Ophira M Ginsburg, Rochelle Demsky, Steven A Narod, David Malkin. Fam Cancer 2012
12
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
12
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, Elias Obeid, Diane D Liu, Angelica M Gutierrez-Barrera, Jennifer K Litton, Olufunmilayo I Olopade, Gabriel N Hortobagyi, Louise C Strong,[...]. Cancer 2012
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, Elias Obeid, Diane D Liu, Angelica M Gutierrez-Barrera, Jennifer K Litton, Olufunmilayo I Olopade, Gabriel N Hortobagyi, Louise C Strong,[...]. Cancer 2012
12
Population Frequency of Germline BRCA1/2 Mutations.
Kara N Maxwell, Susan M Domchek, Katherine L Nathanson, Mark E Robson. J Clin Oncol 2016
Kara N Maxwell, Susan M Domchek, Katherine L Nathanson, Mark E Robson. J Clin Oncol 2016
12
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
Monica Marabelli, Su-Chun Cheng, Giovanni Parmigiani. Genet Epidemiol 2016
Monica Marabelli, Su-Chun Cheng, Giovanni Parmigiani. Genet Epidemiol 2016
12
Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
N J H van Os, N Roeleveld, C M R Weemaes, M C J Jongmans, G O Janssens, A M R Taylor, N Hoogerbrugge, M A A P Willemsen. Clin Genet 2016
N J H van Os, N Roeleveld, C M R Weemaes, M C J Jongmans, G O Janssens, A M R Taylor, N Hoogerbrugge, M A A P Willemsen. Clin Genet 2016
12
A systematic review and meta-analysis of family history and risk of ovarian cancer.
J F Stratton, P Pharoah, S K Smith, D Easton, B A Ponder. Br J Obstet Gynaecol 1998
J F Stratton, P Pharoah, S K Smith, D Easton, B A Ponder. Br J Obstet Gynaecol 1998
12
Inherited p53 gene mutations in breast cancer.
D Sidransky, T Tokino, K Helzlsouer, B Zehnbauer, G Rausch, B Shelton, L Prestigiacomo, B Vogelstein, N Davidson. Cancer Res 1992
D Sidransky, T Tokino, K Helzlsouer, B Zehnbauer, G Rausch, B Shelton, L Prestigiacomo, B Vogelstein, N Davidson. Cancer Res 1992
12
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
12
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
12
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999
12
The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Randi J Cohen, Rochelle E Curtis, Peter D Inskip, Joseph F Fraumeni. Cancer 2005
Randi J Cohen, Rochelle E Curtis, Peter D Inskip, Joseph F Fraumeni. Cancer 2005
12
12
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
12
12
Genetic susceptibility to triple-negative breast cancer.
Kristen N Stevens, Celine M Vachon, Fergus J Couch. Cancer Res 2013
Kristen N Stevens, Celine M Vachon, Fergus J Couch. Cancer Res 2013
12
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
12
Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
12
Screening MR imaging versus screening ultrasound: pros and cons.
Mary C Mahoney, Mary S Newell. Magn Reson Imaging Clin N Am 2013
Mary C Mahoney, Mary S Newell. Magn Reson Imaging Clin N Am 2013
12
Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.